Drugs / PF-00610335
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01043276 | Jan → Apr 2010 | asthma | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-00610335 | “450 µg PF-00610335 using inhaler A” NCT01043276 ↗ |
| Route | Inhaled | “450 µg PF-00610335 using inhaler A” NCT01043276 ↗ |